Phase 2 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 18 years old
- People who have been newly diagnosed with glioblastoma (a type of brain tumour) or whose glioblastoma has come back, and whose doctors have recommended surgery to remove the tumour
Who may not be able to join:
- People for whom MRI or FDG PET scans with contrast dye are not possible
- People who have certain metal implants in their body (such as infusion pumps, pacemakers, or aneurysm clips) that could be unsafe during scanning, as well as people with severe claustrophobia (fear of enclosed spaces) or severely reduced kidney function (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Benjamin Ellingson, PhD, University of California at Los Angeles
Phone: 310-794-8995
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Glycolytic Index; Immunohistochemistry Expression of Glycolytic Molecules
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.